Can't Get Relief From Eczema?

The ARISE-AD Study is enrolling participants now for a potential treatment to reduce symptoms in people with moderate to severe atopic dermatitis.

About the ARISE-AD Study

A Clinical Study to Evaluate a Potential Treatment for Atopic Dermatitis (Eczema)

The ARISE-AD Study will test the safety and effectiveness of the potential drug ANB032 to reduce the pain, itch, skin irritation, and other symptoms caused by AD.

This study will assess the efficacy of the study drug to:

Reduce the skin irritation and other problems that atopic dermatitis causes for people living with AD

Moderate the overreaction in your body’s immune system that results in atopic dermatitis symptoms

Improve peoples’ overall quality of life

The study drug is a novel treatment that may moderate some of the factors that cause overactive immune responses in patients with atopic dermatitis. Modulating the immune system in this way may provide relief from the irritation, pain, itch, and disruption in everyday activities experienced by so many people.

If you or your loved one suffers from irritation and other painful symptoms of atopic dermatitis, then the ARISE-AD Study may be a good option to explore. Please get in touch with your doctor or the local study team and site to learn more. Check the study finder below for the site closest to you.

The ARISE-AD Study Is Looking for Volunteers With Atopic Dermatitis

About 160 eligible patients with atopic dermatitis will be enrolled at multiple study locations across the United States, Canada, Europe, Australia, and New Zealand.

You are eligible* to participate in the study if:

You are aged 18–65

You have been diagnosed with moderate-to-severe atopic dermatitis (also referred to as eczema) continuously for at least 6 months

You have not found relief despite the use of standard treatments for atopic dermatitis

You are in generally good health besides your atopic dermatitis diagnosis

* Additional criteria for eligibility apply

If study investigators determine you are eligible, your participation may help find a potential treatment option for you and others with atopic dermatitis.

If you participate in the ARISE-AD Study, you will be asked to: **

Provide signed informed consent

Comply with all scheduled clinic visits and study-related procedures

Not take any study-prohibited medications during the trial period

Your participation in the ARISE-AD Study is entirely voluntary, and your information will be confidential. If you change your mind, you can withdraw from the study at any time, for any reason, and without any consequences.

** Additional responsibilities apply

What to Expect During the Study?

The study lasts for about 40 weeks consisting of 15 clinic visits to update on your health status, including:

Screening Period

An initial Screening Period of up to 5 weeks with 1 clinic visit

You will undergo assessments to check if you fully qualify to participate in the study

Treatment Period

A Treatment Period of 12 weeks with 7 clinic visits

At randomization and 6 additional visits, you will receive a dose of either ANB032 or an inactive placebo. Each dose consists of 2 injections under the skin

You and your doctor will not know if you received the active drug or the placebo until after the end of the study

Follow-up Period

A Follow-up Period of 24 weeks with 7 clinic visits

This includes follow-ups to ensure your well-being and measure your response to the doses you received

Beyond the initial screening period, the study lasts for about 36 weeks consisting of 14 clinic visits to update on your health status, including: ***

Routine laboratory tests


Physical exam

Vital signs

Standard assessments of the severity of atopic dermatitis symptoms

*** Additional assessments apply

See If You Qualify

Please answer all questions.

Find an ARISE-AD Study Site Near You

For additional information and to find the best location for you, please use the site finder map below.

Search Study Site

1. Progressive Clinical Research

Attn: Jamie Renker

1973 Northwest Loop 410, Suite 106, San Antonio, TX 78213

United States

P: 210-614-5557

Primary Investigator

Dr. Mark Lee

E: drlee@progclin.com

Study Coordinator

Jamie Renker

E: jrenker@progclin.com

2. North Texas Center for Clinical Research

Attn: Ali Ruble

3880 Parkwood Blvd, Suite 102, Frisco, TX 75034

United States

Primary Investigator

Dr. Timothy Rodgers

Study Coordinator

Ali Ruble

P: 214-618-0220

E: ali@ntxclinicalresearch.com

3. Floridian Research Institute

Attn: Giovanna Fernandez

1021 Ives Dairy Rd, Suite 214, Miami, FL 33179

United States

P: 786-391-1137

Primary Investigator

Dr. Gretel Trullenque

4. Center For Dermatology Clinical Research, Inc.

Attn: Evguenia Vals

2557 Mowry Ave, Suite 25, 34, Fremont, CA 94538

United States

Primary Investigator

Dr. Sunil S. Dhawan

Study Coordinator

Evguenia Vals

P: 510-797-0140 ext 3

E: evgueniav@ctr4derm.com

5. Wilmington Dermatology Center

WDC Cosmetic and Research PLLC

Attn: Taylor Thompson

710 Military Cutoff Rd, Suite 320, Wilmington, NC 28405

United States

P: 910-256-4350

E: research@wilmingtondermatologycenter.com

Primary Investigator

Dr. Rosalyn George

6. Darst Dermatology

Attn: Megha Singh

11301 Golf Links Dr North, Suite 2023, Charlotte, NC 28277

United States

Primary Investigator

Dr. Marc Darst

Study Coordinator

Megha Singh

P: (704) 321-3376 ext 1017

E: megha.singh@djlresearch.com

7. Medisearch Clinical Trials

Attn: Heather Jackson

1427 Village Dr , St. Joseph, MO 64506

United States

Primary Investigator

Dr. Melody Stone

Study Coordinator

Heather Jackson

P: 816-364-1515

E: heather.jackson@medisearchderma.com

8. Clinical Science Institute

Attn: Mario Castillo

2001 Santa Monica Blvd., SUITE 1160W & 1185W, Santa Monica, CA 90404

United States

P: 310-828-8887

Primary Investigator

Dr. Yamauchi

Study Coordinator

Mario Castillo

E: mcastillo@csird.com

Study Coordinator

Carolyn Ferguson

E: cferguson@csird.com

9. Oregon Medical Research Center

1750 S. Harbor Way, Suite 330, Portland, OR 97201

United States

P: 503-245-1525

Primary Investigator

Dr. Benjamin Ehst

Study Coordinator

Charlie Blauvelt

E: cblauvelt@oregonmedicalresearch.com

10. Henry Ford Health System

Department of the Dermatology

Attn: Ashkhen Movsisyan

3031 W. Grand Boulevard, NCO 7208, Detroit, MI 48202

United States

P: (313) 916-2600

Primary Investigator

Dr Stein Gold

11. LCC Medical Research Institute

Attn: Jaikelys Tavel

1150 Northwest 72nd Ave., Suite 620, Miami, FL 33126

United States

P: 305-400-0814

Primary Investigator

Duardo Guerra

12. Tennessee Clinical Research Center

Attn: Jamie Tice

2000 Richard Jones Rd, Suite 223, Nashville, TN 37215

United States

P: 615-383-9660

E: research@tnclinicalresearch.com

13. Anthelope Valley Clinical Trials

44453 16th St West, Suite 101, Lancaster, CA 93534

United States

Primary Investigator

Dr. Tan

Study Coordinator

Gabriela Ramirez

P: 661-266-8944

E: gabriela@calallergy.com

14. First OC Dermatology

Attn: Vanessa Montanez

17271 Brookhurst St , Fountain Valley, CA 92708

United States

Primary Investigator

Dr. Laquer

Study Coordinator

Vanessa Montanez

P: 714-531-2966

15. Advanced Medical Research, PC

Attn: Brittney Ray

5730 Glenridge Dr, Suite T-100, Sandy Springs, GA 30328

United States

Primary Investigator

Dr. Jamie Weisman, M.D.

P: 404-939-9220 x 112

Study Coordinator

Brittney Ray

E: bray@atlmedderm.com

Study Coordinator

Marie Edwards

E: medwards@atlmedderm.com

16. Reveal Research Institute

Attn: Cristina Martinez

2110 Research Row, Dallas, TX 75235

United States

Primary Investigator

Dr. Abramovitz

Study Coordinator

Alison Tran, MD

P: 972-797-9297, option 2

E: atran@revealinstitute.com

17. Torrance Clinical Research Institute Inc.

Attn: Mansoreh Afshar

25043 Narbonne Ave., Lomita, CA 90717

United States

Primary Investigator

Dr. Raikhel

Study Coordinator

Mansoreh Afshar

P: 424-203-8982

P: 310-373-8120

E: Mraikhel@msn.com

18. University of Michigan Hospital

Attn: Meghan Patton

1500 E Medical Center Dr, Ann Arbor, MI 48109

United States

P: 734-936-4000

Primary Investigator

Dr. Johann Eli Gudjonsson, MD, PhD

19. DS Research of Southern Indiana

Attn: Kristi Doblado

1005 East Lewis And Clark Pkwy., Clarksville, IN 47129

United States


P: 502-373-2849


Primary Investigator

Dr. Vissing

20. Southern Indiana Clinical Trials

Attn: Christy Nardi

1813 State Street, Suite 200, New Albany, IN 47150

United States

P: 502-373-8133


Primary Investigator

Dr. Megan Landis, Board-Certified Dermatologist

Study Coordinator

Christy Nardi

E: cnardi@soinct.com

21. Dermatologists of Southwest Ohio

Attn: Erica Mihaltian

6110 Radio Way, Mason, OH 45040

United States

Primary Investigator

Dr. Rocco T. Serrao, MD

Study Coordinator

Erica Mihaltian

P: 513-701-5526

E: emihaltian@dermswohio.com

22. Advanced Specialty Research LLC

200 North 3rd Street, Suite 110, Boise, ID 83702

United States

P: 208-906-1600

Primary Investigator

Dr. Bill Laitinen, MD

E: bill@idahoasr.com

Study Coordinator

Jennifer Poralla

E: jennifer@idahoasr.com

23. ActivMed Practices & Research of Alcanza

421 Merrimack St., Methuen, MA 01844

United States

P: 978-451-0831

E: Methuenrecruitment@alcanzaclinical.com

Primary Investigator

Dr. Mancuso

24. Premier Clinical Research

324 S Sherman St, a2, Spokane, WA 99202

United States

P: 509-343-3710

Primary Investigator

Dr. William Werschler

Study Coordinator

Celeste Gray

E: cgray@premierclinicalresearch.com

Study Coordinator

Heather Berg

E: hberg@premierclinicalresearch.com

25. Columbus Clinical Services

110 NW 27th Ave, Miami, FL 33125

United States

P: 305-631-6991

Primary Investigator

Dr. Armando Pineda-Velez

Study Coordinator

Bertha M Cano

E: b.cano@columbusclinical.net

26. R&R Research

8700 W Flagler St., Suite 105, Miami, FL 33174

United States

P: 305-767-9151

Primary Investigator

Dr. Carlos Ricotti

27. International Research Partners

3042 Northwest 82nd Ave. , Doral, FL 33122

United States

P: 305-468-9455

Primary Investigator

Luis Aponte

28. Velocity Clinical Research

5326 O'Donovan Dr., Baton Rouge, LA 70808

United States

P: 225-768-2850

Primary Investigator

Dr. Mary Dobson

E: mdobson@velocityclinical.com

Study Coordinator

Eric Stanford

E: estandford@velocityclinical.com

29. Revival Research Institute

Navya Kamath

1575 West Big Beaver Road, Suite C10, Troy, MI 48084

United States

P: 248-590-0298

Primary Investigator

Dr. Ali Moiin

Study Coordinator

Latoya Simmons

30. Oakland Hills Dermatology

3400 Auburn Road, Suite 100, Auburn Hills, MI 48326

United States

P: 248-858-2255

Primary Investigator

Dr. Christofer Buatti, D.O

Study Coordinator

Tricia Swineford

31. Orange County Research Institute

1801 W Romneya Dr, Suite 409, Anaheim, CA 92801

United States

Primary Investigator

Steve Sitar, MD

Study Coordinator

Cassandra Valdez

P: 714-635-7100

E: cvaldez@ocri.us

32. Core Healthcare Group

17150 Norwalk Boulavard, Suite 102, Cerritos, CA 90703

United States

P: 562-924-8880

Primary Investigator

Dr. Francisco L. Badar

Study Coordinator

Christine Cabrera

E: ccabrera@corehealthcaregroup.com

33. R&H Clinical Research

23215 Red River Drive, Katy, TX 77494

United States

P: 832-886-3275

Primary Investigator

Dr. Syed V. Ahmed

Study Coordinator

Denise Rodriguez

P: 713-367-2791

34. Apex Clinical Trials

4651 Van Dyke Road, Lutz, FL 33558

United States

P: 813-321-1786

Primary Investigator

Dr. Christopher Ewanowski

Study Coordinator

Jennifer Gabriel

P: 813-321-1786 x1796

E: jgabriel@suncoastskin.com

35. Inquest Clinical Research

1690 West Baker Road, Suite B, Baytown, TX 77521

United States

P: 832-641-8718

Primary Investigator

Dr. Haider Afzal, MD

Study Coordinator

Naheed Mehkri

P: 832-606-2053

36. Clinical Research Philadelphia

9501 Roosevelt Blvd, Philadelphia, PA 19144

United States

Primary Investigator

Jason Schoenfeld

Study Coordinator

Annesh Vase

P: 215-676-6696

37. Cura Clinical Research

1064 North Ventura RD, Oxnard, CA 93030

United States

Primary Investigator

Dr. Michael Lin

Study Coordinator

Jamie Goodnight

P: 833-525-2872 ext. 103

E: jgoodnight@curaclinicalresearch.com

38. Pasadena Clinical Trials

65 N Madison Ave., Ste 701, Pasadena, CA 91101

United States

E: info@pasadenatrials.com

Primary Investigator

Amit Paliwal

Study Coordinator

Ha Hoang

P: 626-822-6554

39. Oasis Clinical Research

4488 South Pecos Road, Las Vegas, NV 89121

United States

Primary Investigator

Stephen Tam, MD

P: 702.832.1369

E: stam@oasistrials.com

Study Coordinator

Jeffrey Catallini

P: 702.832.1369

E: jeff@oasistrials.com

40. Indiana Medical Research Institute

8560 Broadway, Merrillville, IN 46410

United States

E: info@indianaclinicalresearch.com

Primary Investigator

Arshad Malik

Study Coordinator

Yelena Quintanilla

P: 219-207-5053

41. Healthcare Research Network

637 Dunn Road, Suite 135, Hazelwood, MO 63042

United States

Primary Investigator

Larry D. Reed

Study Coordinator

Cyndi Puckett

P: 314-972-9600

42. Healthcare Research Network II, LLC

3235 E. Vollmer Road, Unit 147, Flossmoor, IL 60422

United States

Primary Investigator

Ronald Stumbris

Study Coordinator

Taran Parmar

P: 708-388-2245

43. DermEffects - Dr Wei Jing Loo

Attn: Christina Craig

1560 Hyde Park Rd, London, ON N6H 5L5


P: 519-204-6868

E: dermeffects2@gmail.com

E: dermeffects@gmail.com

Primary Investigator

Dr. Loo

Study Coordinator

Christina Craig

44. SimcoDerm Medical and Surgical Dermatology Center

Attn: Ramin Eshtiaghi

5 Quarry Ridge Rd, Suite 105, Barrie, ON L4M 7G1


P: 705-503-6331

E: derm@simcoderm.com

Primary Investigator

Dr. Maryam Shayesteh Alam

45. North Bay Dermatology Centre

Attn: Tiffany Ellacott

500 Cassells St, North Bay, ON P1B 3Z7


Primary Investigator

Dr. Leah Rosoph, MD

P: 705 476-4539

E: nbdcrosoph@gmail.com

46. Enverus Medical Reseaech

Attn: Reena Tut-Parhar

13737 96 Ave, Surrey, BC V3V 0C6


P: 604 495 8278

Primary Investigator

Dr. Lorne Albrecht

Study Coordinator

Reena Tut-Parhar

E: reena@enverusmedical.com

47. Kingsway Dermatology & Cosmetic Centre

Attn: Poornima Kamble

1243 Islington Ave, Suite 1000, Etobicoke, ON M8X 1Y9


Primary Investigator

Dr. Marnie E. Fisher

Study Coordinator

Poornima Kamble

P: 416-231-0100 ext 212

E: poornima.kdc@gmail.com

48. The Centre for Dermatology

Attn: Sarah Dyalsingh

312 Hwy. 7 East, Richmond Hill, ON L4B 1A5


Primary Investigator

Dr. Mani Raman

Study Coordinator

Sarah Dyalsingh

P: (905) 889-2019 x6

E: s.dyalsingh@tcfd.ca

49. East Sydney Doctors

102 Burton Street , Darlinghurst, NSW 2010


P: +612 9332 2531

Primary Investigator

Dr. David Baker

Study Coordinator

Chloe Williamson

E: cwilliamson@eastsydneydoctors.com.au

50. Veracity Clinical Research

250 Ipswich Rd, Level 1, Suite 18, Woolloongabba, QLD 4102


P: 07 3039 1300

E: trials@veracityclinicalresearch.com.au

Primary Investigator

Dr. Lynda Spellman

51. Cornerstone Dermatology

346 Old Cleveland Road, Coorparoo, QLD 4151


P: 0488 789 409

E: trials@cornerstonederm.com.au

Primary Investigator

Dr. Young Jin Kim

Study Coordinator

Margaret Anders

52. LEPL "The First University clinic of Tbilisi State Medical University"

N4 Gudamakari str., Tbilisi , 0141


Primary Investigator


Study Coordinator

Medea Jgarkava

P: +995 599890052

E: mjgarkava@yahoo.com

E: m.jgarkava@tsmu.edu

53. LLC Aversi Clinic

No 27b, Vazha-Pshavela ave., Tbilisi, 0160


Primary Investigator


Study Coordinator

Maka Katsia

P: +995 5933432 66

E: mkatsia@yahoo.com

54. LTD "Acad. N.Kipshidze Central University Clinic"

N 29 Vazha-Pshavela Ave., Tbilisi, 0160


Primary Investigator


Study Coordinator

Maia Kokaia

P: +995 597124477

E: maikokakaia170@gmail.com

55. LLC "Medi Club Georgia"

N22a Tashkenti str., #22 Panjikidze str., (Former Budapeshti str.), Tbilisi, 0160


Primary Investigator


Study Coordinator

Asmat Narsia

P: +995 597505059

E: irma_buchukuri@yahoo.com

56. LTD "Israeli-Georgian Medical Research clinic Helsecore"

N 13g, Tevdore Mgvdeli str., Tbilisi, 0112


Primary Investigator


Study Coordinator

Nana Tateishvili

P: +995 599050169

E: tat99na@gmail.com

57. J.S.C. Curatio

31, Otar Lortkipanidze str., Tbilisi, 0114


Primary Investigator


Study Coordinator

Neli Bakuradze

P: +995 5999023 54

E: Nelly_bakuradze@yahoo.com

58. LLC "Davit Abuladze Georgia-Italian clinic"

N39a, Paliashvili str., Tbilisi, 0179


Primary Investigator


Study Coordinator

Tinatin Shaishmelashvili

P: +995 5585075 55

E: Tinatin.shaishmelashvili@gmail.com

59. Dermoklinika Centrum Medyczne

Al Kosciuszki 93, Lodz, 90-436


Primary Investigator

Aleksandra Lesiak

P: +48 609279389

E: lesiak_ola@interia.pl

60. Tomasz Blicharski Lubelskie Centrum Diagnostyczne

Ul. Drewniana 61, Świdnik , 21-040


Primary Investigator

Tomasz Blicharski

P: +48 509678110

E: blicharski@vp.pl

61. Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska

Śliczna 13, Wrocław , 50-566


Primary Investigator


Study Coordinator

Katarzyna Matusiak

P: +48 514 755 505

E: polaczanska@interia.pl

62. MICS Centrum Medyczne Warszawa

ul. Wronia 53 lok. B10, Warszawa, 00-874


Primary Investigator


Study Coordinator

Kacper Marciniak

P: +48 786 112 990

63. Diamond Clinic Sp Zoo

S. Rogozinskiego 6/U3, Krakow, 31-559


Primary Investigator

Barbara Rewerska

P: +48696049029

E: barbara@diamondclinic.eu

64. High-Med Przychodnia Specjalistyczna

Kasprowicza 27/2, Warszawa, 01-817


Primary Investigator


Study Coordinator

Agata Gora

P: +48 501 782 261

E: agata.gora@high-med.pl

65. Uniwersyteckie Centrum Kliniczne, Department of Dermatology, Venereology and Allergology

Gdański Uniwersytet Medyczny, Katedra i Klinika Dermatologii, Wenerologii i Alergologii Sekretariat

ul. Smoluchowskiego 17, Gdańsk, 80-214


E: dermatologia@gumed.edu.pl

Primary Investigator


Study Coordinator

Agnieszka Grabowska

P: +48 58 584 40 10

E: amalek@uck.gda.pl

66. Klinika Dermatologii Uniwersytecki Szpital Kliniczny Im. F. Chopina In Rzeszów

Ul. Szopena 2, Rzeszów , 35-055


Primary Investigator

Adam Reich

P: +48 605 076 722

E: adi_medicalis@go2.pl

67. Vitamed Gałaj i Cichomski sp.j.

ul. Kościuszki 35, Bydgoszcz, 85-079


Primary Investigator


Study Coordinator

Rafal Cichomski

P: +48 665 102 401

E: r.cichomski@wp.pl

68. Laser Clinic civil partnership dr Tomasz Kochanowski dr Andrzej Krolicki

Al. Piastów 65/U5, Szczecin, 70-332


Primary Investigator


Study Coordinator

Paulina Klen

P: +48 666 400 151

E: paulinazielinska2701@gmail.com

69. A-Derm-Serwis

ul. Waszyngtona 42/3, Częstochowa, 42-217


Primary Investigator


Study Coordinator

Monika Fafrowicz

P: +48 504 251 231

E: monika.fafrowicz@gmail.com

70. dermMedica Sp. Z.o.o.

ul. Krzysztofa Kolumba 6, Wroclaw, 51-503


Primary Investigator


71. ClinMedica Research Ltd.

Ogrodowa 21/23, Skierniewice, 96-100


Primary Investigator


Study Coordinator

Agnieszka Sas-Grzelecka

P: +48 609 702 525

E: sasgrzelecka.a@gmail.com


Ul. Wynalazek 4, Warsaw, 02-677


Primary Investigator


Study Coordinator

Aleksandra Zajac

P: +48 575 000 749

E: a.zajac@etg-network.com

73. Praglandia s.r.o.

Ostrovskeho 253/3, Prague 5, 150 00


Primary Investigator

Andrea Vocilkova

Study Coordinator

Nicole Frankova

P: +420 608052214

E: n.frank@praglandia.cz

74. Clintrial, s.r.o

Počernická 16, Praha 10, 130 00


Primary Investigator

Otakar Komarek

Study Coordinator

Zuzana Procházková

P: +420274778577

E: z.prochazkova@clintrial.cz

75. Pratia Pardubice a.s.

trida Miru 2800, Pardubice, 530 02


Primary Investigator

Andrea Bartlova

Study Coordinator

Pavel Palúch

P: +420608518311

E: Pavel.paluch@ccrpardubice.com

76. Kozni ordinace

Bolzanova 1604/7, Prague 1, 110 00


Primary Investigator

Petr Arenberger

Study Coordinator

Paula Kastierova

P: +420 735750955

E: paula.kastierova@crc-cz.com